Medicina Interna
MEDINT
![Foto de Medicina Interna](/img/grupo.png)
![Foto de Corporació Sanitària Parc Taulí](/img/noimage_org.png)
Corporació Sanitària Parc Taulí
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Corporació Sanitària Parc Taulí (10)
2020
2019
-
Dissemination of health technologies: Trends in the use of diagnostic test in breast cancer screening
Journal of Healthcare Quality Research, Vol. 34, Núm. 4, pp. 177-184
2016
-
First month prednisone dose predicts prednisone burden during the following 11 months: An observational study from the RELES cohort
Lupus Science and Medicine, Vol. 3, Núm. 1
-
Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 34, Núm. 3, pp. 466-472
2014
-
Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82
2013
-
A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 31, Núm. SUPPL.75
-
Evidence of association of the NLRP1 gene with giant cell arteritis
Annals of the Rheumatic Diseases
-
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1882-1886
2012
-
Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population
Clinical and Experimental Rheumatology, Vol. 30, Núm. SUPPL. 70
-
Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279